Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”

Edoardo Gronda; Furio Colivicchi; Giuseppe Zuccala'

doi:10.1161/circulationaha.121.057530

Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”

Edoardo Gronda, Furio Colivicchi, Giuseppe Zuccala'

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	839-840
Numero di pagine	2
Rivista	Circulation
Volume	145
Numero di pubblicazione	16
DOI	https://doi.org/10.1161/circulationaha.121.057530
Stato di pubblicazione	Pubblicato - 2022

All Science Journal Classification (ASJC) codes

Cardiologia e Medicina Cardiovascolare
Fisiologia (medica)

Keywords

Heart failure

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1161/circulationaha.121.057530

Altri file e collegamenti

Cita questo

@article{c4eb16df2ec548daa65d3a5521568bd9,

title = "Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”",

abstract = "N/A",

keywords = "Heart failure, Heart failure",

author = "Edoardo Gronda and Furio Colivicchi and Giuseppe Zuccala'",

year = "2022",

doi = "10.1161/circulationaha.121.057530",

language = "English",

volume = "145",

pages = "839--840",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”

AU - Gronda, Edoardo

AU - Colivicchi, Furio

AU - Zuccala', Giuseppe

PY - 2022

Y1 - 2022

N2 - N/A

AB - N/A

KW - Heart failure

UR - https://publicatt.unicatt.it/handle/10807/281778

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85128573955&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85128573955&origin=inward

U2 - 10.1161/circulationaha.121.057530

DO - 10.1161/circulationaha.121.057530

M3 - Article

SN - 0009-7322

VL - 145

SP - 839

EP - 840

JO - Circulation

JF - Circulation

IS - 16

ER -

Letter by Gronda et al Regarding Article, “Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial”

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo